Clinical Trial

Evaluation of Efficacy, Safety and Molecular Mechanism of Pentoxifylline Supplementation in Patients With Hepatic and Obstructive Jaundice

Completed Phase 2
View on ClinicalTrials.gov →
Summary
Investigating the efficacy, safety, and molecular mechanism of Pentoxifylline supplementation in improving elevated direct bilirubin level and liver function tests in patients with hepatic and post-hepatic jaundice
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-04-18; most recent amendment 2026-07-20.
Trial Details
NCT Number NCT06944704
Lead Sponsor Tanta University
Conditions Hepatobiliary Disorders
Enrollment 45 participants
Start Date 2024-04-03
Primary Completion 2025-03-19 (estimated)
Study Completion 2025-03-19 (estimated)
Updated on ClinicalTrials.gov 2026-07-21